Surface-Layer Protein A (SlpA) is a major contributor to host-cell adherence of clostridium difficile

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Merrigan, Michelle M ^a   Venugopal, Anilrudh ^b   Roxas, Jennifer L ^f   Anwar, Farhan ^f   Mallozzi, Michael J ^f   Roxas, Bryan A P ^f   Gerding, Dale N ^c,d   Viswanathan, V K ^e,f,g   Vedantam, Gayatri ^e,f,g,h  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HINES VA HOSPITAL   (United States)

^d LOYOLA UNIVERSITY CHICAGO   (United States)

^e School of Animal and Comparative Biomedical Sciences   (United States)

^f UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF ARIZONA   (United States)

^h SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; RECOMBINANT PROTEIN; SURFACE LAYER PROTEIN A; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CELL; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN SUBUNIT; STRAIN DIFFERENCE;

BACTERIAL ADHESION; BACTERIAL PROTEINS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; EPITHELIAL CELLS; GENOTYPE; HUMANS; SPECIES SPECIFICITY;

EID: 84893189808     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078404     Document Type: Article

References (49)

1. Viswanathan VK, Mallozzi MJ, Vedantam G (2010) Clostridium difficile infection: An overview of the disease and its pathogenesis, epidemiology and interventions. Gut Microbes 1: 234-242.
2. O'Connor JR, Johnson S, Gerding DN (2009) Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 136: 1913-1924.
3. Kyne L, Farrell RJ, Kelly CP (2001) Clostridium difficile. Gastroenterol Clin North Am 30: 753-777, ix-x. (Pubitemid 32880451)
4. Vedantam G, Clark A, Chu M, McQuade R, Mallozzi M, et al. (2012) Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response. Gut Microbes 3: 121-134.
5. Hamm EE, Ballard JD (2007) Elucidating the in vivo targets of bacterial toxins. Future Microbiol 2: 85-92. (Pubitemid 46767000)
6. Lyras D, O'Connor JR, Howarth PM, Sambol SP, Carter GP, et al. (2009) Toxin B is essential for virulence of Clostridium difficile. Nature 458: 1176-1179.
7. Kuehne SA, Cartman ST, Minton NP (2011) Both, toxin A and toxin B, are important in Clostridium difficile infection. Gut Microbes 2: 252-255.
8. Tasteyre A, Barc MC, Collignon A, Boureau H, Karjalainen T (2001) Role of FliC and FliD flagellar proteins of Clostridium difficile in adherence and gut colonization. Infect Immun 69: 7937-7940. (Pubitemid 33086630)
9. Hennequin C, Janoir C, Barc MC, Collignon A, Karjalainen T (2003) Identification and characterization of a fibronectin-binding protein from Clostridium difficile. Microbiology 149: 2779-2787. (Pubitemid 37279253)
10. Barketi-Klai A, Hoys S, Lambert-Bordes S, Collignon A, Kansau I (2011) Role of fibronectin-binding protein A in Clostridium difficile intestinal colonization. J Med Microbiol 60: 1155-1161.
11. Ternan NG, Jain S, Srivastava M, McMullan G (2012) Comparative transcriptional analysis of clinically relevant heat stress response in Clostridium difficile strain 630. PLoS ONE 7: e42410.
12. Waligora AJ, Hennequin C, Mullany P, Bourlioux P, Collignon A, et al. (2001) Characterization of a cell surface protein of Clostridium difficile with adhesive properties. Infect Immun 69: 2144-2153. (Pubitemid 32239680)
13. Calabi E, Calabi F, Phillips AD, Fairweather NF (2002) Binding of Clostridium difficile surface layer proteins to gastrointestinal tissues. Infect Immun 70: 5770-5778.
14. Calabi E, Fairweather N (2002) Patterns of sequence conservation in the S-Layer proteins and related sequences in Clostridium difficile. J Bacteriol 184: 3886-3897. (Pubitemid 34705446)
15. Calabi E, Ward S, Wren B, Paxton T, Panico M, et al. (2001) Molecular characterization of the surface layer proteins from Clostridium difficile. Mol Microbiol 40: 1187-1199. (Pubitemid 32574985)
16. Kirby JM, Ahern H, Roberts AK, Kumar V, Freeman Z, et al. (2009) Cwp84, a surface-associated cysteine protease, plays a role in the maturation of the surface layer of Clostridium difficile. J Biol Chem 284: 34666-34673.
17. Takeoka A, Takumi K, Koga T, Kawata T (1991) Purification and characterization of S layer proteins from Clostridium difficile GAI 0714. J Gen Microbiol 137: 261-267.
18. Fagan RP, Albesa-Jove D, Qazi O, Svergun DI, Brown KA, et al. (2009) Structural insights into the molecular organization of the S-layer from Clostridium difficile. Mol Microbiol 71: 1308-1322.
19. Karjalainen T, Waligora-Dupriet AJ, Cerquetti M, Spigaglia P, Maggioni A, et al. (2001) Molecular and genomic analysis of genes encoding surface-anchored proteins from Clostridium difficile. Infect Immun 69: 3442-3446. (Pubitemid 32332247)
20. Cerquetti M, Molinari A, Sebastianelli A, Diociaiuti M, Petruzzelli R, et al. (2000) Characterization of surface layer proteins from different Clostridium difficile clinical isolates. Microb Pathog 28: 363-372.
21. Sara M, Sleytr UB (2000) S-Layer proteins. J Bacteriol 182: 859-868. (Pubitemid 30075004)
22. Antikainen J, Anton L, Sillanpaa J, Korhonen TK (2002) Domains in the S-layer protein CbsA of Lactobacillus crispatus involved in adherence to collagens, laminin and lipoteichoic acids and in self-assembly. Mol Microbiol 46: 381-394. (Pubitemid 35340951)
23. Schneitz C, Nuotio L, Lounatma K (1993) Adhesion of Lactobacillus acidophilus to avian intestinal epithelial cells mediated by the crystalline bacterial cell surface layer (S-layer). J Appl Bacteriol 74: 290-294. (Pubitemid 23076261)
24. Dingle KE, Didelot X, Ansari MA, Eyre DW, Vaughan A, et al. (2013) Recombinational switching of the Clostridium difficile S-layer and a novel glycosylation gene cluster revealed by large-scale whole-genome sequencing. J Infect Dis 207: 675-686.
25. Eggertson L, Sibbald B (2004) Hospitals battling outbreaks of C. difficile. Cmaj 171: 19-21.
26. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, et al. (2005) A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353: 2442-2449. (Pubitemid 41770165)
27. McDonald LC, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, et al. (2005) An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353: 2433-2441. (Pubitemid 41770164)
28. Petrella LA, Sambol SP, Cheknis A, Nagaro K, Kean Y, et al. (2012) Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain. Clin Infect Dis 55: 351-357.
29. Akerlund T, Persson I, Unemo M, Noren T, Svenungsson B, et al. (2008) Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1. J Clin Microbiol 46: 1530-1533. (Pubitemid 351563610)
30. Stabler RA, Gerding DN, Songer JG, Drudy D, Brazier JS, et al. (2006) Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains. J Bacteriol 188: 7297-7305. (Pubitemid 44547635)
31. Marsh JW, O'Leary MM, Shutt KA, Pasculle AW, Johnson S, et al. (2006) Multilocus variable-number tandem-repeat analysis for investigation of Clostridium difficile transmission in Hospitals. J Clin Microbiol 44: 2558-2566. (Pubitemid 44092427)
32. Samore M, Killgore G, Johnson S, Goodman R, Shim J, et al. (1997) Multicenter typing comparison of sporadic and outbreak Clostridium difficile isolates from geographically diverse hospitals. J Infect Dis 176: 1233-1238. (Pubitemid 27460988)
33. Sambol SP, Tang JK, Merrigan MM, Johnson S, Gerding DN (2001) Infection of hamsters with epidemiologically important strains of Clostridium difficile. J Infect Dis 183: 1760-1766. (Pubitemid 32523238)
34. Jhung MA, Thompson AD, Killgore GE, Zukowski WE, Songer G, et al. (2008) Toxinotype V Clostridium difficile in humans and food animals. Emerg Infect Dis 14: 1039-1045. (Pubitemid 351920432)
35. Walker AS, Eyre DW, Wyllie DH, Dingle KE, Griffiths D, et al. (2013) Relationship Between Bacterial Strain Type, Host Biomarkers, and Mortality in Clostridium difficile Infection. Clin Infect Dis 56: 1589-1600.
36. Eidhin DN, Ryan AW, Doyle RM, Walsh JB, Kelleher D (2006) Sequence and phylogenetic analysis of the gene for surface layer protein, slpA, from 14 PCR ribotypes of Clostridium difficile. J Med Microbiol 55: 69-83. (Pubitemid 43031241)
37. Merrigan M, Venugopal A, Mallozzi M, Roxas B, Viswanathan VK, et al. (2010) Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J Bacteriol 192: 4904-4911.
38. Fagan RP, Janoir C, Collignon A, Mastrantonio P, Poxton IR, et al. (2011) A proposed nomenclature for cell wall proteins of Clostridium difficile. J Med Microbiol 60: 1225-1228.
39. Sambol SP, Merrigan MM, Tang JK, Johnson S, Gerding DN (2002) Colonization for the prevention of Clostridium difficile disease in hamsters. J Infect Dis 186: 1781-1789. (Pubitemid 35463511)
40. Merrigan MM, Sambol SP, Johnson S, Gerding DN (2009) New approach to the management of Clostridium difficile infection: colonisation with non-toxigenic C. difficile during daily ampicillin or ceftriaxone administration. Int J Antimicrob Agents 33 Suppl 1: S46-50.
41. Figueroa I, Johnson S, Sambol SP, Goldstein EJ, Citron DM, et al. (2012) Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin. Clin Infect Dis 55 Suppl 2: S104-109.
42. Vohra P, Poxton IR (2011) Comparison of toxin and spore production in clinically relevant strains of Clostridium difficile. Microbiology 157: 1343-1353.
43. Burns DA, Heeg D, Cartman ST, Minton NP (2011) Reconsidering the sporulation characteristics of hypervirulent Clostridium difficile BI/NAP1/027. PLoS One 6: e24894.
44. Selma MV, Larrosa M, Beltran D, Lucas R, Morales JC, et al. (2012) Resveratrol and Some Glucosyl, Glucosylacyl, and Glucuronide Derivatives Reduce Escherichia coli O157:H7, Salmonella Typhimurium, and Listeria monocytogenes Scott A Adhesion to Colonic Epithelial Cell Lines. J Agric Food Chem 60:7367-7374.
45. Spigaglia P, Barketi-Klai A, Collignon A, Mastrantonio P, Barbanti F, et al. (2013) Surface-Layer (S-Layer) of Human and Animal Clostridium difficile Strains and Their Behaviour in Adherence to Epithelial Cells and Intestinal Colonization. J Med Microbiol 62(9): 1386-1393.
46. Ausiello CM, Cerquetti M, Fedele G, Spensieri F, Palazzo R, et al. (2006) Surface layer proteins from Clostridium difficile induce inflammatory and regulatory cytokines in human monocytes and dendritic cells. Microbes Infect 8: 2640-2646. (Pubitemid 44573879)
47. Pechine S, Janoir C, Boureau H, Gleizes A, Tsapis N, et al. (2007) Diminished intestinal colonization by Clostridium difficile and immune response in mice after mucosal immunization with surface proteins of Clostridium difficile . Vaccine 25: 3946-3954. (Pubitemid 46617001)
48. Jandu N, Zeng ZJ, Johnson-Henry KC, Sherman PM (2009) Probiotics prevent enterohaemorrhagic Escherichia coli O157:H7-mediated inhibition of interferon-gamma-induced tyrosine phosphorylation of STAT-1. Microbiology 155: 531-540.
49. Tam Dang TH, Fagan RP, Fairweather NF, Tate EW (2012) Novel inhibitors of surface layer processing in Clostridium difficile. Bioorg Med Chem 20: 614-621.